Cytosorbents Corporation (CTSO)
USD 0.99
(-1.0%)
USD 0.99
(-1.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -31.2 Million USD | 3.07% |
| 2022 | -31.52 Million USD | -38.59% |
| 2021 | -22.74 Million USD | -119.33% |
| 2020 | -10.37 Million USD | 45.35% |
| 2019 | -18.97 Million USD | -21.75% |
| 2018 | -15.58 Million USD | -58.34% |
| 2017 | -9.84 Million USD | 14.35% |
| 2016 | -11.49 Million USD | -23.52% |
| 2015 | -9.3 Million USD | -27.82% |
| 2014 | -7.27 Million USD | -54.44% |
| 2013 | -4.71 Million USD | -35.02% |
| 2012 | -3.49 Million USD | 21.32% |
| 2011 | -4.43 Million USD | -57.11% |
| 2010 | -2.82 Million USD | -16.23% |
| 2009 | -2.42 Million USD | 25.1% |
| 2008 | -3.24 Million USD | -5.79% |
| 2007 | -3.06 Million USD | -3.45% |
| 2006 | -2.96 Million USD | -3605.39% |
| 2005 | -80 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.86 Million USD | 46.93% |
| 2024 Q2 | -3.23 Million USD | 33.48% |
| 2023 Q4 | -9.16 Million USD | -24.65% |
| 2023 Q2 | -6.55 Million USD | 16.89% |
| 2023 Q1 | -7.89 Million USD | -24.16% |
| 2023 Q3 | -7.35 Million USD | -12.06% |
| 2023 FY | -30.55 Million USD | 3.07% |
| 2022 Q3 | -9.01 Million USD | -7.9% |
| 2022 Q4 | -6.35 Million USD | 29.51% |
| 2022 Q2 | -8.35 Million USD | -7.26% |
| 2022 FY | -31.52 Million USD | -38.59% |
| 2022 Q1 | -7.79 Million USD | 18.51% |
| 2021 Q4 | -9.56 Million USD | -76.86% |
| 2021 FY | -22.74 Million USD | -119.33% |
| 2021 Q1 | -2.85 Million USD | -8.27% |
| 2021 Q2 | -4.92 Million USD | -72.66% |
| 2021 Q3 | -5.4 Million USD | -9.77% |
| 2020 Q1 | -2.47 Million USD | 54.36% |
| 2020 Q2 | -3.29 Million USD | -33.02% |
| 2020 Q4 | -2.63 Million USD | -34.4% |
| 2020 Q3 | -1.96 Million USD | 40.56% |
| 2020 FY | -10.37 Million USD | 45.35% |
| 2019 Q1 | -4.28 Million USD | 23.28% |
| 2019 FY | -18.97 Million USD | -21.75% |
| 2019 Q2 | -3.62 Million USD | 15.29% |
| 2019 Q3 | -5.62 Million USD | -55.01% |
| 2019 Q4 | -5.43 Million USD | 3.48% |
| 2018 Q1 | -3.1 Million USD | 18.5% |
| 2018 Q2 | -4.18 Million USD | -35.04% |
| 2018 FY | -15.58 Million USD | -58.34% |
| 2018 Q3 | -2.71 Million USD | 35.27% |
| 2018 Q4 | -5.58 Million USD | -106.05% |
| 2017 Q3 | -2.14 Million USD | 7.8% |
| 2017 FY | -9.84 Million USD | 14.35% |
| 2017 Q1 | -1.55 Million USD | 65.92% |
| 2017 Q2 | -2.33 Million USD | -49.66% |
| 2017 Q4 | -3.8 Million USD | -77.06% |
| 2016 Q2 | -2.68 Million USD | -28.58% |
| 2016 Q1 | -2.09 Million USD | 21.51% |
| 2016 FY | -11.49 Million USD | -23.52% |
| 2016 Q4 | -4.57 Million USD | -113.15% |
| 2016 Q3 | -2.14 Million USD | 20.21% |
| 2015 Q4 | -2.66 Million USD | -23.83% |
| 2015 FY | -9.3 Million USD | -27.82% |
| 2015 Q3 | -2.15 Million USD | 3.46% |
| 2015 Q2 | -2.22 Million USD | 17.86% |
| 2015 Q1 | -2.71 Million USD | 11.24% |
| 2014 Q3 | -1.68 Million USD | -21.92% |
| 2014 Q2 | -1.38 Million USD | -19.83% |
| 2014 Q1 | -1.15 Million USD | -14.92% |
| 2014 FY | -7.27 Million USD | -54.44% |
| 2014 Q4 | -3.05 Million USD | -81.17% |
| 2013 Q4 | -1 Million USD | -14.15% |
| 2013 Q1 | -1.42 Million USD | -74.95% |
| 2013 Q2 | -1.4 Million USD | 1.08% |
| 2013 Q3 | -879.84 Thousand USD | 37.46% |
| 2013 FY | -4.71 Million USD | -35.02% |
| 2012 FY | -3.49 Million USD | 21.32% |
| 2012 Q1 | -1.06 Million USD | 10.84% |
| 2012 Q3 | -601.17 Thousand USD | 40.45% |
| 2012 Q2 | -1 Million USD | 5.41% |
| 2012 Q4 | -812.92 Thousand USD | -35.22% |
| 2011 Q4 | -1.19 Million USD | 30.77% |
| 2011 Q1 | -1.21 Million USD | -155.65% |
| 2011 Q2 | -1.34 Million USD | -10.42% |
| 2011 Q3 | -1.72 Million USD | -28.91% |
| 2011 FY | -4.43 Million USD | -57.11% |
| 2010 Q2 | -676.27 Thousand USD | 30.21% |
| 2010 Q4 | -475.1 Thousand USD | 39.74% |
| 2010 Q3 | -788.43 Thousand USD | -16.58% |
| 2010 FY | -2.82 Million USD | -16.23% |
| 2010 Q1 | -969.05 Thousand USD | -6463.61% |
| 2009 Q4 | 15.22 Thousand USD | 101.81% |
| 2009 Q2 | -851.94 Thousand USD | -12.08% |
| 2009 Q1 | -760.15 Thousand USD | -16.34% |
| 2009 FY | -2.42 Million USD | 25.1% |
| 2009 Q3 | -841.05 Thousand USD | 1.28% |
| 2008 Q2 | 811.29 Thousand USD | 225.48% |
| 2008 FY | -3.24 Million USD | -5.79% |
| 2008 Q1 | -646.57 Thousand USD | -7.19% |
| 2008 Q4 | -653.41 Thousand USD | 24.92% |
| 2008 Q3 | -870.33 Thousand USD | -207.28% |
| 2007 Q2 | -617.9 Thousand USD | 46.7% |
| 2007 FY | -3.06 Million USD | -3.45% |
| 2007 Q4 | -603.21 Thousand USD | 12.09% |
| 2007 Q3 | -686.15 Thousand USD | -11.04% |
| 2007 Q1 | -1.15 Million USD | -28.39% |
| 2006 Q4 | -903.02 Thousand USD | -35.07% |
| 2006 Q1 | -9899.00 USD | -25.78% |
| 2006 Q3 | -668.54 Thousand USD | -14.98% |
| 2006 FY | -2.96 Million USD | -3605.39% |
| 2006 Q2 | -581.44 Thousand USD | -5773.79% |
| 2005 FY | -80 Thousand USD | 0.0% |
| 2005 Q4 | -7870.00 USD | 18.04% |
| 2005 Q3 | -9602.00 USD | 51.99% |
| 2005 Q2 | -20 Thousand USD | -100.0% |
| 2005 Q1 | -10 Thousand USD | 60.02% |
| 2004 Q4 | -25.01 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -117.319% |
| Cerus Corporation | -30.05 Million USD | -3.847% |
| OrthoPediatrics Corp. | -25.76 Million USD | -21.126% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -193.835% |
| Talis Biomedical Corporation | -66.81 Million USD | 53.29% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -80.442% |
| Inogen, Inc. | -109.38 Million USD | 71.469% |
| Spectral AI, Inc. | -12.98 Million USD | -140.367% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 50.136% |
| CVRx, Inc. | -43.1 Million USD | 27.594% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -784.616% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -151.12% |
| Orthofix Medical Inc. | -139.11 Million USD | 77.565% |
| Venus Concept Inc. | -28.3 Million USD | -10.245% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 42.235% |
| Bioventus Inc. | -81.72 Million USD | 61.812% |
| BrainsWay Ltd. | -4.92 Million USD | -533.433% |
| Envoy Medical, Inc. | -18.37 Million USD | -69.883% |
| electroCore, Inc. | -18.8 Million USD | -65.963% |
| IceCure Medical Ltd | -15.57 Million USD | -100.368% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 35.627% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -80.734% |
| MaxCyte, Inc. | -48.29 Million USD | 35.383% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -161.051% |
| Nexalin Technology, Inc. | -5.69 Million USD | -447.887% |
| PAVmed Inc | -68.79 Million USD | 54.634% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 44.824% |
| RxSight, Inc. | -50.08 Million USD | 37.687% |
| Sight Sciences, Inc. | -57.27 Million USD | 45.509% |
| SI-BONE, Inc. | -46.93 Million USD | 33.5% |
| TELA Bio, Inc. | -44.07 Million USD | 29.191% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 42.365% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 39.315% |
| LivaNova PLC | -68.49 Million USD | 54.438% |
| 908 Devices Inc. | -42.75 Million USD | 27.01% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 82.001% |
| Nemaura Medical Inc. | -9.59 Million USD | -225.258% |
| NeuroPace, Inc. | -27.17 Million USD | -14.85% |
| LENSAR, Inc. | -12.22 Million USD | -155.207% |
| Apyx Medical Corporation | -17.25 Million USD | -80.829% |
| Cutera, Inc. | -156.23 Million USD | 80.024% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -262.73% |
| BioSig Technologies, Inc. | -28.51 Million USD | -9.46% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 64.389% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -39.041% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 127.984% |
| Axonics, Inc. | -26.05 Million USD | -19.773% |
| Outset Medical, Inc. | -169.77 Million USD | 81.617% |
| IRIDEX Corporation | -10 Million USD | -211.874% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 71.412% |
| IRadimed Corporation | 20.03 Million USD | 255.77% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -278.523% |
| INVO Bioscience, Inc. | -6.76 Million USD | -361.187% |
| Telesis Bio, Inc. | -35.15 Million USD | 11.211% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 317.79% |
| Varex Imaging Corporation | 32.1 Million USD | 197.225% |
| Quipt Home Medical Corp. | 3.91 Million USD | 896.358% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -157.226% |
| Pulmonx Corporation | -61.93 Million USD | 49.61% |
| Dynatronics Corporation | -2.27 Million USD | -1273.013% |
| Modular Medical, Inc. | -17.52 Million USD | -78.044% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -113.193% |
| Semler Scientific, Inc. | 22.25 Million USD | 240.228% |
| InMode Ltd. | 195.66 Million USD | 115.951% |
| Bruker Corporation | 436.9 Million USD | 107.143% |
| DexCom, Inc. | 597.7 Million USD | 105.222% |
| Align Technology, Inc. | 643.33 Million USD | 104.851% |
| Viveve Medical, Inc. | -21.55 Million USD | -44.802% |
| ZimVie Inc. | -30.93 Million USD | -0.874% |
| Movano Inc. | -29.69 Million USD | -5.117% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -12.082% |
| Nexalin Technology, Inc. | -5.69 Million USD | -447.887% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -784.616% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 86.619% |
| Profound Medical Corp. | -28.61 Million USD | -9.062% |
| Insulet Corporation | 220 Million USD | 114.186% |
| enVVeno Medical Corporation | -25.23 Million USD | -23.66% |
| Surmodics, Inc. | -5.64 Million USD | -452.865% |
| iCAD, Inc. | -7.68 Million USD | -305.895% |
| Nuwellis, Inc. | -17.63 Million USD | -77.024% |
| Biotricity, Inc. | -8.82 Million USD | -253.515% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 75.065% |
| Aethlon Medical, Inc. | -12.63 Million USD | -146.976% |
| InspireMD, Inc. | -21.14 Million USD | -47.61% |
| PAVmed Inc. | -68.79 Million USD | 54.634% |
| BIOLASE, Inc. | -17.93 Million USD | -73.994% |
| Beyond Air, Inc. | -63 Million USD | 50.466% |
| FONAR Corporation | 16.53 Million USD | 288.742% |
| AxoGen, Inc. | -21.46 Million USD | -45.416% |
| Vivani Medical, Inc. | -26.96 Million USD | -15.74% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 272.991% |
| Inari Medical, Inc. | -14.03 Million USD | -122.415% |
| UFP Technologies, Inc. | 57.66 Million USD | 154.123% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -533.356% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -394.932% |
| Tenon Medical, Inc. | -15.72 Million USD | -98.444% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -317.571% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 26.921% |
| AdaptHealth Corp. | -598.4 Million USD | 94.785% |
| Sintx Technologies, Inc. | -13.35 Million USD | -133.637% |
| NanoVibronix, Inc. | -3.43 Million USD | -808.302% |
| Quanterix Corporation | -49.7 Million USD | 37.206% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -157.226% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -8069.962% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 90.669% |
| TransMedics Group, Inc. | -28.72 Million USD | -8.641% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -32.175% |
| NeuroMetrix, Inc. | -7.15 Million USD | -336.4% |
| Hyperfine, Inc. | -48.11 Million USD | 35.136% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 52.005% |
| Biomerica, Inc. | -6.36 Million USD | -390.172% |
| Bone Biologics Corporation | -9.42 Million USD | -231.017% |
| AVITA Medical, Inc. | -40.4 Million USD | 22.753% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -202.673% |
| Silk Road Medical, Inc | -59.27 Million USD | 47.345% |